HeXell-2020

DRUG2 trials

Sponsors

Hexun Biosciences Co., LTD.

Conditions

Coronary Artery DiseaseFrailty in Older Adults

Phase 1

Safety and Preliminary Effectiveness Study of Mesenchymal Stem Cells, HeXell-2020, in Patients With Stable Coronary Artery Disease

Not yet recruitingNCT07137104

Hexun Biosciences Co., LTD.Coronary Artery Disease

Start: 2025-12-01End: 2028-07-31Target: 39Updated: 2025-08-22

Safety and Tolerability Study of Mesenchymal Stem Cells, HeXell-2020, in Elderly Subjects With Mild to Moderate Frailty Syndrome

Not yet recruitingNCT07144072

Hexun Biosciences Co., LTD.Frailty in Older Adults

Start: 2026-01-31End: 2028-07-31Target: 12Updated: 2025-09-04